Training, tracking and preparation tips for managing your relapsing MS therapy with COPAXONE®.

Getting started with COPAXONE®

How to Start

An introduction to the free assistance that COPAXONE® is known for, with Teva’s Shared Solutions® and the original autoject®2 for glass syringe.

Pick your path
Preparation for COPAXONE® including before, during and after checklist


Your complete before, during and after checklist, including training assistance for COPAXONE® patients throughout their MS experience.

Be prepared
COPAXONE® injection training for injections, guidance for travel, storing and disposal of supplies

COPAXONE® Injection Training

Convenient, in-person tips for injecting COPAXONE®, plus guidance for travel, storing and disposing of supplies.

Get expert tips
Injection tracking with Teva's tracking app for MS therapy

Injection Tracking

The COPAXONE iTracker® 2.0 is your app-y place for keeping MS therapy on track, from recording your injections to customizing information for your next appointment.

Download the app
COPAXONE® and generics, receiving the prescribed RMS prescription from your doctor

COPAXONE® and Generics

Information you need to know to ensure you receive your prescribed RMS medication from your doctor—and your pharmacy.

Know your rights


COPAXONE® (glatiramer acetate injection) is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

Important Safety Information

Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Some patients report a short-term reaction right after or within minutes after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heart beat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.

A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please see full Prescribing Information for Teva's COPAXONE®.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?